Pediatric Solid Tumor Program at Phoenix Children's Hospital

Phoenix Children's Hospital's Solid Tumor Program is the only comprehensive program in the Southwest offering treatment expertise for children with cancer or benign tumors, apart from those originating in the brain, blood, or bone marrow. We pride ourselves on making a significant difference in the quality of life for our patients, and we strive to be recognized internationally as a Pediatric Center of Excellence for Solid Tumors.

Led by Masayo Watanabe, MD, the Solid Tumor Program uses the most up-to-date clinical trials, research collaborations, and evidence-based practices currently available to children diagnosed with a wide variety of solid tumors.

A Solid Tumor is a mass of suspicious nature, which can be found anywhere on or in the body, with unknown potential for abnormal growth and/or spreading (metastasizing) that occurs unexpectedly. For our program, it is further defined as a Solid Tumor that is neither hematopoietic in origin (occurring in the blood or bone marrow) nor a central nervous system tumor.

Why Choose Phoenix Children's Hospital

Phoenix Children's has the largest pediatric cancer program in Arizona and is a leading participant in research to find cures for childhood cancer. The Hospital is a long-standing member of Children's Oncology Group (COG), a national research consortium, and one of three COG members in the state. Our Oncology Program is also an active participant in the Pediatric Oncology Experimental Therapeutic Investigator Consortium (POETIC), a Phase I consortium composed of 10 large academic medical centers in the United States and Canada. Additionally, we participate in cutting edge research with the Neuroblastoma Medulloblastoma Translational Research Consortium (NMTRC), and with Translational Genomics Research Institute (TGen), and provide care and research in coordination with Mayo Clinic of Scottsdale. Our vast array of partnerships allows eligible patients to participate in the newest protocols and treatments.

Our coordination with other institutions, such as Memorial Sloan Kettering Cancer Center (NYC), MD Anderson Cancer Center (Houston), Rady Children's Hospital (San Diego), and Children's Hospital of Los Angeles, allows patients to have consultation at those institutions, while receiving treatment in Phoenix.

Phoenix Children's is also developing a specific Solid Tumor research program and is currently receiving support for this endeavor from the University of Arizona, Arizona State University, and from interested donors throughout the entire Southwest United States.

Treating Children and Educating Families

Diseases and malignancies impact children and adults differently. Medical literature shows that children and young adults fare better with child protocols than adult protocols, which is why Phoenix Children's uses treatments geared for pediatric patients. In some cases, a young adult might be better suited for an adult program. Our specialists are always on hand to help you find the best program fit for your child. In general, adult solid tumors have a 20 percent cure rate. Our pediatric program has a 66 percent cure rate.

With all our pediatric patients, an emphasis is placed on teaching family members how to cope with the diagnosis and treatment, and what to expect moving forward. The goal is for parents to teach their child how to be an advocate for themselves and eventually take over their own care.

We also help with insurance needs, how to plan for ongoing treatment, and champion the importance of going to school, getting a good job, and receiving good health insurance.

Contact Us

(602) 933-0920

Share this page: